| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $49,997 | 2 | 67 |
Sells | $732 | 1 | 33 |
| CARUSO JAMES V | Chief Executive Officer | 1 | $24,998 | 0 | $0 | $24,998 |
| Longcor Jarrod | Chief Operating Officer | 1 | $24,998 | 0 | $0 | $24,998 |
| NEIS JOHN | director | 0 | $0 | 1 | $732 | $-732 |
Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosine I-131), a phospholipid drug conjugate (PDC), which is currently undergoing several clinical evaluations. It is in Phase 2 clinical trials for individuals with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies. Additionally, CLR 131 is being studied in Phase 2B for r/r multiple myeloma (MM) and in Phase I trials …
Over the last 12 months, insiders at Cellectar Biosciences, Inc. have bought $49,997 and sold $732 worth of Cellectar Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Cellectar Biosciences, Inc. have bought $91,573 and sold $732 worth of stock each year.
Highest buying activity among insiders over the last 12 months: CARUSO JAMES V (Chief Executive Officer) — $24,998. Longcor Jarrod (Chief Operating Officer) — $24,998.
The last purchase of 8,680 shares for transaction amount of $24,998 was made by Longcor Jarrod (Chief Operating Officer) on 2026‑05‑07.
| 2026-05-07 | Longcor Jarrod | Chief Operating Officer | 8,680 0.2373% | $2.88 | $24,998 | -24.09% | ||
| 2026-05-07 | CARUSO JAMES V | Chief Executive Officer | 8,680 0.2373% | $2.88 | $24,998 | -24.09% | ||
| 2025-12-12 | Sale | NEIS JOHN | director | 198 0.0063% | $3.70 | $732 | -25.69% | |
| 2025-07-02 | Longcor Jarrod | Chief Operating Officer | 10,000 0.0229% | $4.99 | $49,900 | -30.02% | ||
| 2025-07-02 | CARUSO JAMES V | Chief Executive Officer | 10,000 0.0229% | $4.99 | $49,900 | -30.02% | ||
| 2025-07-02 | Kolean Chad J | Chief Financial Officer | 5,000 0.0114% | $4.99 | $24,950 | -30.02% | ||
| 2025-01-10 | Longcor Jarrod | Chief Operating Officer | 30,000 0.0723% | $0.28 | $8,400 | -34.95% | ||
| 2021-09-14 | Swirsky Douglas J | director | 25,000 0.0418% | $1.04 | $26,000 | -43.80% | ||
| 2021-09-03 | DRISCOLL FREDERICK W | director | 19,417 0.0328% | $1.04 | $20,244 | -42.72% | ||
| 2021-03-04 | CARUSO JAMES V | President and CEO | 5,100 0.0103% | $1.70 | $8,659 | -43.68% | ||
| 2020-12-28 | Longcor Jarrod | Chief Business Officer | 29,630 0.0975% | $1.35 | $40,001 | -41.79% | ||
| 2020-12-28 | CARUSO JAMES V | President and CEO | 37,037 0.1219% | $1.35 | $50,000 | -41.79% | ||
| 2020-12-28 | Elefant Dov | Chief Financial Officer | 7,407 0.0244% | $1.35 | $9,999 | -41.79% | ||
| 2020-06-05 | Longcor Jarrod | Chief Business Officer | 65,218 0.4749% | $1.15 | $74,675 | +26.32% | ||
| 2020-06-05 | CARUSO JAMES V | President and CEO | 21,740 0.1583% | $1.15 | $24,892 | +26.32% | ||
| 2020-06-05 | Elefant Dov | Chief Financial Officer | 4,348 0.0317% | $1.15 | $4,978 | +26.32% | ||
| 2020-06-04 | HILL STEPHEN A | director | 18,000 0.1236% | $1.08 | $19,438 | +25.88% | ||
| 2019-02-28 | Longcor Jarrod | Chief Business Officer | 100 0.0021% | $2.00 | $200 | +6.90% | ||
| 2018-11-30 | CARUSO JAMES V | President and CEO | 1,000 0.0345% | $2.28 | $2,282 | -4.93% | ||
| 2018-11-29 | Sale | HILL STEPHEN A | director | 992 0.0329% | $2.21 | $2,192 | -5.78% |
| Longcor Jarrod | Chief Operating Officer | 20451 0.2164% | $26,790.81 | 7 | 1 | <0.0001% |
| CARUSO JAMES V | Chief Executive Officer | 20318 0.215% | $26,616.58 | 11 | 1 | <0.0001% |
| NEIS JOHN | director | 10 0.0001% | $13.10 | 3 | 2 | |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10 percent owner | 1142368 12.0859% | $1.5M | 4 | 0 | |
| Hertzberg Richard | 280000 2.9623% | $366,800.00 | 12 | 1 | ||
| BERNS PAUL L | director | 117371 1.2417% | $153,756.01 | 1 | 0 | |
| Swirsky Douglas J | director | 25000 0.2645% | $32,750.00 | 1 | 0 | |
| DRISCOLL FREDERICK W | director | 19417 0.2054% | $25,436.27 | 1 | 0 | |
| HILL STEPHEN A | director | 18000 0.1904% | $23,580.00 | 3 | 1 | +25.88% |
| Pedder Simon | President and CEO | 13300 0.1407% | $17,423.00 | 1 | 0 | |
| Elefant Dov | Chief Financial Officer | 11755 0.1244% | $15,399.05 | 2 | 0 | <0.0001% |
| Kolean Chad J | Chief Financial Officer | 6418 0.0679% | $8,407.58 | 1 | 0 | <0.0001% |
$18,815,063 | 62 | -6.45% | $13.7M | |
$1,993,425 | 46 | -21.91% | $13.95M | |
$95,567,744 | 39 | -17.01% | $10.94M | |
$30,257,839 | 29 | -15.72% | $12M | |
$76,600 | 22 | -38.58% | $10.49M |
| Increased Positions | 11 | +50% | 107,201 | +36.11% |
| Decreased Positions | 7 | -31.82% | 57,242 | -19.28% |
| New Positions | 4 | New | 38,410 | New |
| Sold Out Positions | 6 | Sold Out | 57,226 | Sold Out |
| Total Postitions | 26 | +18.18% | 346,838 | +16.83% |
| Bleichroeder Lp | $347.00 | 2.5% | 100,000 | +100,000 | New | 2025-09-30 |
| Vanguard Group Inc | $226.00 | 1.63% | 65,171 | +8,830 | +15.67% | 2025-09-30 |
| Renaissance Technologies Llc | $86.00 | 0.62% | 24,900 | +24,900 | New | 2025-09-30 |
| Geode Capital Management, Llc | $86.00 | 0.62% | 24,892 | +10,453 | +72.39% | 2025-09-30 |
| Drw Securities, Llc | $73.00 | 0.53% | 21,101 | +21,101 | New | 2025-09-30 |
| Citadel Advisors Llc | $64.00 | 0.46% | 18,526 | +18,526 | New | 2025-09-30 |
| Dimensional Fund Advisors Lp | $45.00 | 0.33% | 13,033 | +13,033 | New | 2025-09-30 |
| Sequoia Financial Advisors, Llc | $37.00 | 0.27% | 10,783 | +10,783 | New | 2025-09-30 |
| Riverview Capital Advisers, Llc | $36.00 | 0.26% | 10,384 | -116 | -1.1% | 2025-09-30 |
| Blackrock, Inc. | $16.00 | 0.12% | 4,745 | +3 | +0.06% | 2025-09-30 |